INVO Fertility, Inc. (IVF) stock
IVFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.60−0.08 (-3.17%)
Close on Nov 13, 2026Market cap $6.52MP/E –Yield –
INVO Fertility r&d expenses
Research and development expenses are spending on new products and technology.
INVO Fertility's R&D Expenses for the twelve months ending Dec 31, 2024 was $4.88K, down 97.1% year over year. For fiscal 2024 it was $4.88K, down 97.1% from the year before. The highest annual figure on record is $544.04K in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.88K | -97.1% |
| FY2023 | Dec 31, 2023 | $165.95K | -69.5% |
| FY2022 | Dec 31, 2022 | $544.04K | +151.4% |
| FY2021 | Dec 31, 2021 | $216.43K | -45.7% |
| FY2020 | Dec 31, 2020 | $398.43K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $4.88K | -93.4% |
| Q4 FY2023 | Dec 31, 2023 | $5.91K | -92.0% |
| Q3 FY2023 | Sep 30, 2023 | $2.67K | -98.5% |
| Q2 FY2023 | Jun 30, 2023 | $83.85K | -56.0% |
| Q1 FY2023 | Mar 31, 2023 | $73.52K | -29.4% |
| Q4 FY2022 | Dec 31, 2022 | $73.84K | +15.8% |
| Q3 FY2022 | Sep 30, 2022 | $175.27K | +216.4% |
| Q2 FY2022 | Jun 30, 2022 | $190.76K | +515.0% |
| Q1 FY2022 | Mar 31, 2022 | $104.18K | +57.2% |
| Q4 FY2021 | Dec 31, 2021 | $63.76K | -71.1% |
| Q3 FY2021 | Sep 30, 2021 | $55.39K | -50.8% |
| Q2 FY2021 | Jun 30, 2021 | $31.02K | -11.1% |
| Q1 FY2021 | Mar 31, 2021 | $66.27K | +120.5% |
| Q4 FY2020 | Dec 31, 2020 | $220.93K | – |
| Q3 FY2020 | Sep 30, 2020 | $112.55K | – |
| Q2 FY2020 | Jun 30, 2020 | $34.89K | – |
| Q1 FY2020 | Mar 31, 2020 | $30.05K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | – |
See a number that looks wrong?